ClinicalTrials.Veeva

Menu

Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Oral Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT00173316
9461700614

Details and patient eligibility

About

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Full description

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Sex

All

Ages

18 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • oral cancer and oral precancer specimens

Exclusion criteria

  • other diseases

Trial contacts and locations

1

Loading...

Central trial contact

Chun-Pin Chiang, DMSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems